AusDoc research reveals the five biggest challenges facing Australian practice managers, from staffing shortages and compliance to costs and patient demand.
What Really Influences a GP’s Choice of Pharma Company of the Year?
What makes a pharmaceutical company stand out to Australian GPs? Breakthrough medicines, quality medical education, knowledgeable representatives or meaningful support for patients? An analysis of nominations for the PRIME Awards' GPs' Choice: Pharma Company of the Year, spanning 2024 to 2026, reveals what doctors genuinely value.
GP26: Make your conference presence go further with AusDoc
Maximise your brand’s visibility before and after the RACGP GP26 National Conference in Adelaide, 20–22 November 2026. AusDoc offers sponsors and exhibitors targeted advertising, newsletter sponsorships, branded content and dedicated email campaigns to reach thousands of Australian GPs. Explore our tailored GP26 partnership packages to build awareness, drive engagement and extend your conference impact beyond the event.
ADHD Care in Australia: GPs are willing, but the system isn’t ready
ADHD care in Australia is shifting to GPs faster than the system can support. An AusDoc survey of 213 GPs reveals where the pressure is landing, why existing guidance isn't reaching practice, and what GPs say it will take to fix it.
The doctors who fear AI most are using it the most
New AusDoc research shows Australian GPs aren't waiting for AI to earn their trust before they use it. For AI vendors targeting the profession, that's not a barrier to plan around, it's an opening.
AusDoc Confirmed #1 in Print, Digital and Newsletter Engagement
The 2026 GP Readership Survey found AusDoc remained the leading independent medical publisher among Australian GPs across print, website and email newsletter engagement. Among respondents, 72% had read Australian Doctor within the relevant print cycle, while 59% engaged with the AusDoc website and 62% with AusDoc newsletters within the previous day or week, ahead of all surveyed competitors.
THE UNCOMFORTABLE TRUTH 2 by AusDoc – You think this is working? We don’t.
Last year, over 1,000 Australian doctors gave us The Uncomfortable Truth about how they really see pharma. This year we went further — 1,417 doctors, plus 80+ pharma fieldbased employees, for the full picture from both sides of the fence. Register your interest for a private debrief of the AusDoc BIG Doctor Survey 2026, before the findings go public and explore what they mean for your HCP strategy.
How patient research is reshaping the GP consultation and pharma’s role in it
Australian GPs are increasingly entering consultations that have already started without them. Patients arrive with self-researched diagnoses, treatment preferences, and safety concerns sourced from Google, AI tools, and social media. Read how for pharma this shift redefines the engagement opportunity.
What pharma companies actually want from their agency partners and what they’re not getting
The Australian pharmaceutical sector has a reasonably healthy relationship with its communications agencies. A new survey of pharma and biotech professionals shows 85% rate the agencies they work with as Good or better. That's a solid foundation and when you ask the best relationships to describe what great looks like, the answer is clear: “Real partners, they understand both commercial and strategic challenges.” The gap between that experience and the average one is the story worth telling.
What Australian Doctors Want from Pharma – Insights from 1,430 GPs and specialists
Australian doctors say the biggest opportunities for the pharmaceutical industry lie in four areas: improving access to medicines, providing practical clinical support, maintaining trust and transparency, and helping make healthcare easier to navigate. These findings come from the AusDoc BIG Doctor Survey (Sept 2025, n=1,430).
Top 5 Clinical Areas Where Australian GPs Want More Support
GPs are managing more complexity than ever before, from rising patient expectations to evolving treatment pathways and time pressures within the consult. While GPs remain the cornerstone of patient care, there are clear areas where additional support from the broader healthcare ecosystem, including pharma, can make a meaningful difference.
The Millennial Majority: What Pharma Must Prepare for as the Next Generation of Doctors Reshapes Engagement in Australia
Australian medicine is entering a generational transition, with millennials set to become the largest cohort as baby boomer and Generation X doctors retire over the next decade. This is a challenge because trust in pharma companies is particularly low among younger clinicians. This whitepaper draws on recent research to help pharma marketers, sales and medical teams’ future proof their engagement with the next generation of clinicians over the next five to ten years.